Service alert

AMA Says Doctors Make Clinical Decisions, Not AI

11/17/2026
Podcast

November 17, 2026

Who can be licensed as a physician? Not AI

Fluid eMTBR-tau243 as a Biomarker of Mixed 3-Repeat and 4-Repeat Tau Pathology

Sparking Interest in Pathology Award

RVS Update Committee (RUC)

Nick Lanyi

The AMA says doctors must make clinical decisions, not AI. Researchers find a potential biomarker for CTE. And why the ruck matters. These stories and more are coming up next. Welcome to CAP News. I'm Nick Lanyi with the College of American Pathologists. It's Tuesday, November 17th. Here's what's making news in pathology and laboratory medicine. Physicians must oversee the use of artificial intelligence in clinical decision making under a policy adopted by the American Medical Association at its interim meeting last week. The AMA House of Delegates adopted a policy calling for AI-enabled technologies to be integrated into physician-led teams and used at the direction of the treating physician. The policy also endorsed the position that AI cannot be granted a physician license, professional title, or certification to practice medicine. The AMA will support legislation that codifies these principles and also protects physicians against liability for choosing not to use an AI tool or follow an AI recommendation. The AMA policy comes amid its rollout of AI governance policies that began last month. A new study holds out hope that a blood test could someday be used to diagnose chronic traumatic encephalopathy , or CTE. The degenerative brain disease is associated with former football players and others who have had multiple concussions or blows to the head. It can cause behavioral changes, memory loss, and dementia. But so far, disease can only be confirmed through autopsy. But in a study published in the Journal of the American Medical Association, researchers at Washington University in St. Louis tested the blood of patients who had died and been diagnosed with CTE. They found that levels of a biomarker were higher than normal in those with advanced CTE. The biomarker was a fragment of tau, the brain protein that can cause toxic tangles associated with Alzheimer's and CTE. December 1st is the deadline to apply for the CAP Foundation's Sparking Interest in Pathology Award. Funding up to $500 is available to medical students for projects or initiative that inspire other medical students to pursue a career in pathology. Examples include establishing a pathology student interest group, hosting interactive education sessions, or creating network opportunities between students and practicing pathologists. To apply, visit the CAP Foundation website. And finally, every pathologist should be familiar with RUC, the thankfully short acronym for the American Medical Association Specialty Society Relative Value Scale Update Committee. The Centers for Medicare and Medicaid Services decided not to change Medicare reimbursements for surgical pathology services in 2027, but they are likely to revisit them down the road. If so, the RUC process could be crucial to proving pathology's value. The RUC is a panel of primary and specialty physicians from national medical societies, including the CAP, that makes recommendations to the CMS about the relative value of medical services, based heavily on evidence provided by each specialty. The CMS traditionally accepts most of the recommendations. Here's Dr. Theresa Emory, Chair of the CAP's Economic Affairs Committee.

Dr. Theresa Emory

So every service we report has a code describing it, and how that service is described in value affects the resources available to us to provide care. For example, interpreting a biopsy may involve reviewing clinical information, comparing previous specimens, selecting additional studies, and discussing findings with a treating physician. The work can vary considerably, even among cases reported under the same code. And we pathologists need to be able to explain that work clearly to people outside of our specialty and support our assessments with accurate information.

Nick Lanyi

Some of that information comes from surveys that collect information about what's going on in laboratories across the country.

Dr. Theresa Emory

That's why participation in the RUC surveys matter. These surveys help assess physician work and practice resources. Thoughtful responses from pathologists across different practice settings help ensure that recommendations reflect daily practice.

Nick Lanyi

The CAP urges pathologists to participate in RUC surveys to help demonstrate pathology's value. That's all for today. See the show notes for more information on today's stories. And if you have a story you'd like us to cover, write to us at stories at CAP.org. We'll be back Wednesday at 5 AM Eastern with another edition of CAP News. I'm Nick Lanyi. Have a wonderful day.